The difference between ‘Staging’ and ‘Grading’ breast cancer
When someone is diagnosed with breast cancer, one of the most common questions I hear is:
What’s the difference between staging and grading?
Although these terms may sound similar, they describe very different aspects of the disease. Both are important in understanding your diagnosis, planning treatment and talking about prognosis.
What is Breast Cancer Staging?
Staging refers to how much cancer there is and where it is located.
In essence, it tells us about the size of the tumour and whether the cancer has spread beyond the initial site. Understanding the stage helps your treating team make informed decisions about which treatments are likely to be most effective.
The most widely used method to describe stage is called the TNM system. This stands for:
- T (Tumour): the size of the primary tumour
- N (Nodes): whether cancer cells have been found in nearby lymph nodes
- M (Metastasis): whether cancer has spread to distant parts of the body (such as bones, liver, lungs or brain).
Once these factors are assessed using a combination of physical examination, imaging and pathology, they are combined into a stage group.
- Stage 0 describes pre-invasive disease (for example, ductal carcinoma in situ or DCIS), where abnormal cells are present but have not spread.
- Stages 1 and 2 generally describe early breast cancer that is confined to the breast and possibly a few nearby lymph nodes.
- Stage 3 refers to locally advanced cancers that have spread further within the breast region or adjacent tissues.
- Stage 4 means cancer has spread to distant parts of the body – also known as metastatic disease.
In general, lower stage cancers (e.g. Stage 1) tend to have more treatment options and better long-term outcomes, while higher stages indicate more extensive disease and may require broader treatment approaches.
What is Breast Cancer Grading?
Grading refers to how the cancer cells look under a microscope and gives an indication of how quickly they may be growing.
A pathologist examines a tumour sample and evaluates how abnormal the cells appear compared with normal breast tissue. The more abnormal the cells, the more rapidly the cancer is likely to multiply.
Breast cancer is typically graded on a scale of Grade 1 to Grade 3:
- Grade 1 (low grade): cancer cells look more like normal cells and tend to grow slowly
- Grade 2 (intermediate grade): cells are moderately different and grow somewhat faster
- Grade 3 (high grade): cells look very different and tend to grow and spread faster.
Grading does not describe how far the cancer has spread (that’s staging), but it does help guide treatment decisions and gives insight into how aggressively the cancer may behave.
Why do both matter?
Understanding both stage and grade provides a deeper picture of the cancer.
- Stage tells us where the cancer is and how far it’s spread.
- Grade tells us how aggressive the cancer cells are.
Together, they help your medical team tailor treatment – whether that’s surgery alone.
What does it mean for you?
For many patients, hearing “stage 1” or “grade 3” can feel overwhelming, but it’s important to remember that these terms are tools doctors use to plan the best possible treatment – they are not definitive predictors of outcome on their own.
Modern breast cancer care is highly personalised, and many women with high-grade or higher-stage cancers still do very well with the appropriate treatment and support.
If you’ve been diagnosed with breast cancer, you should feel comfortable asking your chosen specialist to explain stage, grade and other elements in plain language.
Here, every question is welcome. Understanding your disease and your options empowers you to make informed choices about your treatment. I leave enough time in my appointments to ensure patients don’t feel rushed.
If you’d like to discuss your breast cancer diagnosis, ask your GP for a referral.
